WHITEHOUSE, N.J.--(BUSINESS WIRE)--Intertek, a leading quality solutions provider to industries worldwide, has been invited to instruct industry peers on the benefits of solventless sample preparation prior to mass spectrometric analysis, during Pittcon 2016, Atlanta, GA, USA, which is the world’s largest annual conference and exposition for laboratory sciences.
The need to minimize risks to patient and consumer health posed by harmful substances in medicines or foods has spurred the requirement for highly efficient sample preparation and testing. Sample preparation can often be labour-intensive, involving multiple steps, where each step has the potential to introduce errors and loss of sample. In addition, disposal of solvents can incur potential increases to cost and impact on the environment.
Using solventless sample preparation such as solid-phase micro extraction (SPME) brings the benefits of miniaturized sample preparation, combining high-speed analysis, reduced cost and an environmentally friendly operation due to minimal or no solvent consumption, integrated with highly selective testing.
Dr. Gyorgy Vas, Intertek’s thought leader on trace analysis, will train industry delegates from the pharmaceutical, environmental, food, and packaging industries as part of the short course program at Pittcon 2016. The course will provide examples and best practice for solventless sample preparation and how it can be used to identify the presence and confirm levels of harmful substances in pharmaceutical or food products.
“A strategic approach to solventless sample preparation can achieve highly selective analysis and very low levels of detection in pharmaceuticals which can help to determine if impurities are present which may pose a risk to the patient, whilst offering the benefits of enhanced efficiency in laboratory testing,” explained Dr. Gyorgy Vas. “This Pittcon course is based on our knowledge, gained over many years, of successful application of solventless sample preparation approaches, including trace level pharmaceutical testing, extractables and leachables and genotoxic impurity testing.”
Pittcon (March 6th-10th) will host a technical program which covers the latest research in more than 2,000 technical presentations covering a diverse selection of methodologies and applications.
Intertek has over 20 years’ experience in conducting Good Manufacturing Practice (GMP) compliant analytical studies supporting pharmaceutical development, including quantitative analysis for trace metals and trace organic substances, pharmaceutical active ingredient (API) analysis, stability studies and extractables and leachables studies.
Find out more:
Intertek is a leading quality solutions provider to industries worldwide. From auditing and inspection, to testing, training, advisory, quality assurance and certification, Intertek adds value for its customers by helping improve the quality and safety of their products, assets and processes. With a network of more than 1,000 laboratories and offices and over 38,000 people in more than 100 countries, Intertek supports companies’ success in the global marketplace, by helping customers to meet end users’ expectations for safety, sustainability, performance, integrity and desirability in virtually any market worldwide. Visit www.intertek.com.